Unity Biotechnology (UBX) News Today → This AI Trade Machine Made 1,729%* (With 89% Wins) (From Prosper Trading Academy) (Ad) Free UBX Stock Alerts $1.50 +0.02 (+1.35%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineUNITY Biotechnology Announces Upcoming Presentations at the ARVO 2024 Annual Meetingglobenewswire.com - April 25 at 8:00 AMUNITY Biotechnology Announces Extension of Phase 2b ASPIRE Clinical Study Evaluating UBX1325 in DMEglobenewswire.com - April 23 at 8:00 AMEquities Analysts Issue Forecasts for Unity Biotechnology, Inc.'s FY2024 Earnings (NASDAQ:UBX)americanbankingnews.com - April 19 at 2:31 AMQ1 2024 Earnings Forecast for Unity Biotechnology, Inc. Issued By HC Wainwright (NASDAQ:UBX)americanbankingnews.com - April 18 at 1:26 AMUBX Stock Earnings: Unity Biotechnology Beats EPS for Q4 2023investorplace.com - April 15 at 12:06 PMUNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updatesglobenewswire.com - April 15 at 7:00 AMUnity Biotechnology, Inc. (0YC0.L)finance.yahoo.com - April 9 at 7:15 PMUBX Mar 2024 2.000 callfinance.yahoo.com - February 17 at 6:28 AMUnity Biotechnology Inc (UBX)uk.investing.com - February 7 at 9:59 AMNew Publication in Nature Medicine Supports Therapeutic Potential of Senolytics to Provide Long-lasting, Disease-modifying Intervention in Vision Lossfinance.yahoo.com - February 6 at 10:46 AM10 Supplements for Longevity and Antiaging: Expert Recommendationsfinance.yahoo.com - December 29 at 6:53 PMUNITY Biotechnology Doses First Patients in Phase 2 ASPIRE Study of UBX1325 in DMEfinance.yahoo.com - December 12 at 8:12 AMUnity Biotechnology (UBX) Price Target Increased by 8.33% to 6.63msn.com - November 27 at 7:50 AMWedbush Upgrades Unity Biotechnology (UBX)msn.com - November 17 at 6:09 AMWedbush upgrades Unity Biotechnology to outperform, cites cash runwaymsn.com - November 16 at 4:06 PMCompanies Like Unity Biotechnology (NASDAQ:UBX) Could Be Quite Riskyfinance.yahoo.com - November 16 at 11:05 AMUnity Biotechnology’s Promising Senolytic Therapy UBX1325 and Financial Stability Bolsters Buy Ratingmarkets.businessinsider.com - November 15 at 11:51 AMUnity Biotechnology, Inc.: UNITY Biotechnology, Inc. Reports Third Quarter 2023 Financial Results and Business Updatesfinanznachrichten.de - November 14 at 10:45 PMUnity Biotechnology GAAP EPS of -$1.05 misses by $0.16msn.com - November 14 at 2:01 AMUNITY Biotechnology, Inc. Reports Third Quarter 2023 Financial Results and Business Updatestmcnet.com - November 13 at 9:00 PMUNITY Biotechnology, Inc. Reports Third Quarter 2023 Financial Results and Business Updatesfinance.yahoo.com - November 13 at 9:00 PMUNITY Biotechnology to exercise warrants for $4.38M in gross proceedsmsn.com - November 10 at 2:17 PMUNITY Biotechnology Announces Exercise of Warrants for $4.38 Million in Gross Proceedsfinance.yahoo.com - November 10 at 9:16 AMAre Longevity Stocks the Next Trillion-Dollar Industry? 3 Anti-Aging Picksfinance.yahoo.com - October 25 at 8:48 AM20 Foods Consumed By Longest Living People Every Dayfinance.yahoo.com - October 3 at 11:19 PMAnalysts Offer Insights on Healthcare Companies: Unity Biotechnology (UBX) and Rockwell Med (RMTI)markets.businessinsider.com - September 28 at 10:01 AMUNITY Biotechnology Reports Encouraging Results From Phase 2 ENVISION Study Of UBX1325markets.businessinsider.com - September 27 at 8:17 AMUNITY Biotechnology Announces 48-Week Results from Phase 2 ENVISION Study of UBX1325 in Patients with Wet Age-Related Macular Degenerationfinance.yahoo.com - September 27 at 8:17 AMUnity Biotechnology Inc CEO Anirvan Ghosh Sells 1,246 Sharesfinance.yahoo.com - September 16 at 9:31 AM20 States With The Longest Life Expectancy In Americafinance.yahoo.com - August 15 at 7:36 PMAnalyst Ratings for Unity Biotechnologymarkets.businessinsider.com - August 9 at 1:47 PMUNITY Biotechnology, Inc. Reports Second Quarter 2023 Financial Results and Business Updatesfinance.yahoo.com - August 8 at 5:47 PMUnity Biotechnology, Inc. Common Stock (UBX)nasdaq.com - July 9 at 1:22 PMDirector at Unity Biotechnology Acquires Company Stock Options Worth 6,000 Sharesbenzinga.com - June 27 at 11:33 AMUnity Biotechnology Board Member Awarded $16K Worth of Stock Optionsbenzinga.com - June 27 at 11:33 AMThe Latest Analyst Ratings for Unity Biotechnologymarkets.businessinsider.com - June 26 at 9:12 AMUNITY Announces Design of Phase 2b ASPIRE Study Evaluating UBX1325 in Diabetic Macular Edema (DME)finance.yahoo.com - June 21 at 10:13 AMWedbush Sticks to Its Buy Rating for Unity Biotechnology (UBX)markets.businessinsider.com - May 15 at 9:42 PMHC Wainwright & Co. Reiterates Unity Biotechnology (UBX) Buy Recommendationmsn.com - May 10 at 6:54 PMUnity Biotechnology (UBX) Gets a Buy from H.C. Wainwrightmarkets.businessinsider.com - May 10 at 8:54 AMUNITY Biotechnology, Inc. Reports First Quarter 2023 Financial Results and Business Updatesyahoo.com - May 9 at 7:32 PMUNITY Biotechnology, Inc. Reports First Quarter 2023 Financial Results and Business Updatesfinance.yahoo.com - May 9 at 7:32 PMWhere Unity Biotechnology Stands With Analystsmarkets.businessinsider.com - April 25 at 12:03 PMUnity Biotechnology (UBX) Gets a Buy from Wedbushmarkets.businessinsider.com - April 25 at 12:03 PMWedbush Maintains Unity Biotechnology (UBX) Outperform Recommendationmsn.com - April 25 at 12:03 PMUnity Biotechnology (UBX) Receives a Rating Update from a Top Analystmarkets.businessinsider.com - April 24 at 4:03 PMUnity Touts Positive Data From Diabetic Macular Edema Study, Plans Head-To-Head Study With Regeneron's Eyleafinance.yahoo.com - April 24 at 4:03 PMUNITY Biotechnology Announces Positive 48-Week Results from Phase 2 BEHOLD Study of UBX1325 in Patients with Diabetic Macular Edemafinance.yahoo.com - April 24 at 10:56 AMUnusual Call Option Trade in Unity Biotechnology (UBX) Worth $15.00Kmsn.com - April 21 at 12:35 AMExpert Ratings for Unity Biotechnologymarkets.businessinsider.com - March 28 at 1:25 PM Get Unity Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for UBX and its competitors with MarketBeat's FREE daily newsletter. Email Address These AI trades triggered this morning (545% return) (Ad)If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy UBX Media Mentions By Week UBX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. UBX News Sentiment▼0.000.33▲Average Medical News Sentiment UBX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. UBX Articles This Week▼20▲UBX Articles Average Week Get Unity Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for UBX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Sensei Biotherapeutics News Today Vaxxinity News Today Enlivex Therapeutics News Today Lipocine News Today Eyenovia News Today Iterum Therapeutics News Today DURECT News Today Qilian International Holding Group News Today CytoMed Therapeutics News Today Oncternal Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:UBX) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingProtect Your Bank Account Before It’s Too LateWeiss RatingsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyWall Street Legend Issues New NVDA WarningChaikin AnalyticsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Unity Biotechnology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
